Chryseobacterium meningosepticum: An emerging pathogen among immunocompromised adults

Medicine

Volumn 76, Issue 1, 1997, Pages 30-41

  Bloch, Karen C ^a   Nadarajah, Rohan ^a   Jacobs, Richard ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CEFTIZOXIME; CIPROFLOXACIN; CLINDAMYCIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL PNEUMONIA; BACTERIUM ISOLATION; BONE MARROW TRANSPLANTATION; BREAST CARCINOMA; CHOLANGITIS; CHRYSEOBACTERIUM MENINGOSEPTICUM; CLINICAL ARTICLE; FEMALE; HODGKIN DISEASE; HUMAN; IMMUNE DEFICIENCY; INFECTION RISK; MALE; NEUTROPENIA; PRIORITY JOURNAL; SEPSIS; SPLENECTOMY;

ADULT; AGED; ANTI-BACTERIAL AGENTS; ANTIBIOTICS, ANTITUBERCULAR; BREAST NEOPLASMS; CIPROFLOXACIN; DRUG RESISTANCE, MICROBIAL; FEMALE; FLAVOBACTERIUM; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; INFANT; INFANT, NEWBORN; LEUKEMIA, MYELOCYTIC, ACUTE; LIVER TRANSPLANTATION; MALE; MENINGITIS, BACTERIAL; MIDDLE AGED; MINOCYCLINE; PNEUMONIA, BACTERIAL; RIFAMPIN; SEPSIS; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 0031026793     PISSN: 00257974     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005792-199701000-00003     Document Type: Article

References (84)

1. Aber RC, Wennersten C, Moellering R Jr. Antimicrobial susceptibility of flavobacteria. Antimicrob Agents Chemother 14: 483-87, 1978.
2. Abrahamsen TG, Finne PH, Lingaas E. Flavobacterium meningosepticum infections in a neonatal intensive care unit. Acta Paediatr Scand 78: 51-55, 1989.
3. Abter EI, Lutwick LI, Torrey MJ, Mann R. Cellulltis associated with bacteremia due to Flavobacterium meningosepticum [letter]. Clin Infect Dis 17: 929-30, 1993.
4. Agarwal KC, Ray M. Meningitis in a newborn due to Flavobacterium meningosepticum. Ind J Med Res 59: 1006-9, 1971.
5. Ashdown LR, Previtera S. Community acquired Flavobacterium meningosepticum pneumonia and septicaemia [letter]. Med J Aust 156: 69-70, 1992.
6. Babiker MA, Taha SA. Meningitis in children of Riyadh. J Trop Med Hyg 87: 245-48, 1984.
7. Berry W, Morrow A, Harrison D, Hochstein H, Himmelsbach C. Flavobacterium septicemia following intracardiac operations. J Thorac Cardiovasc Surg 45: 476-81, 1963.
8. Bhutta ZA, Naqvi SH. Successful eradication of Flavobacterium meningosepticum neonatal meningitis with ceftizoxime. Jpn J Pak Med Assoc 41: 141-42, 1991.
9. Bolivar R, Abramovits W. Cutaneous infection caused by Flavobacterium meningosepticum [letter]. J Infect Dis 159: 150-51, 1989.
10. Brody J, Moore H, Eo K. Meningitis caused by an unclassified Gram-negative bacterium in newborn infante. Am J Dis Child 96: 1-5, 1958.
11. Brown RB, Phillips D, Barker MJ, Pieczarka R, Sands M, Teres D. Outbreak of nosocomial Flavobacterium meningosepticum respiratory infections associated with use of aerosolized polymyxin B. Am J Infect Control 17: 121-25, 1989.
12. Bruun B, Jensen ET, Lundstrom K, Andersen GE. Flavobacterium meningosepticum infection in a neonatal ward. Eur J Clin Microbiol Infect Dis 8: 509-14, 1989.
13. Bucci F Jr, Holland EJ. Flavobacterium meningosepticum keratitis successfully treated with topical trimethoprim-sulfamethoxazole [letter]. Am J Ophthalmol 111: 116-18, 1991.
14. Burnakis TG, Mioduch HJ, LeBar WD, Yalamanchi RR. Sepsis from Flavobacterium meningosepticum, an uncommon pathogen with unusual susceptibility patterns. South Med J 79: 518-19, 1986.
15. Cabrera H, Davis G. Epidemic meningitis of the newborn caused by Flavobacteria. Am J Dis Child 101: 289-95, 1961.
16. Chan KH, Chau PY, Wang RY, Huang CY. Meningitis caused by Flavobacterium meningosepticum after transsphenoidal hypophysectomy with recovery. Surg Neurol 20: 294-96, 1983.
17. Chandrika T, Adler SP. A case of neonatal meningitis due to Flavobacterium meningosepticum successfully treated with rifampin. Pediatr Infect Dis 1: 40-41, 1982.
18. Conti R, Parenti F. Rifampin therapy for brucellosis, Flavobacterium meningitis, and cutaneous leishmaniasis. Rev Infect Dis 5: S600-S605, 1983.
19. Coyle-Gilchrist MM, Crewe P, Roberts G. Flavobacterium meningosepticum in the hospital environment. J Clin Pathol 29: 824-26, 1976.
20. Dooley JR, Nims LJ, Lipp VH, Beard A, Delaney LT. Meningitis of infants caused by Flavobacterium meningosepticum: Report of a patient and analysis of 63 infections. J Trop Pediatr 26: 24-30, 1980.
21. du Moulin GC. Airway colonization by Flavobacterium in an intensive care unit. J Clin Microbiol 10: 155-60, 1979.
22. DuPont HL, Spink WW. Infections due to Gram-negative organisms: An analysis of 860 patients with bacteremia at the University of Minnesota Medical Center, 1958-1966. Medicine (Baltimore) 48: 307-32, 1969.
23. Eykens A, Eggermont E, Eeckels R, Vandepitte J, Spaepen J. Neonatal meningitis caused by Flavobacterium meningosepticum. Helv Paediatr Acta 28: 421-25, 1973.
24. Farr B. Rifamycins. In: Mandell G, Bennett J, Dolin R, eds. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. New York: Churchill Livingstone, 1995.
25. Ferlauto JJ, Wells DH. Flavobacterium meningosepticum in the neonatal period. South Med J 74: 757-59, 1981.
26. Fujita J, Hata Y, Irino S. Respiratory infection caused by Flavobacterium meningosepticum [letter]. Lancet 335: 544, 1990.
27. Garcia-Rodriguez JA, Fresnadillo MJ, Garcia MI, Garcia-Sanchez E, Garcia-Sanchez JE, Trujillano I. Multicenter Spanish study of ciprofloxacin susceptibility in Gram-negative bacteria The Spanish Study Group on Quinolone Resistance. Eur J Clin Microbiol Infect Dis 14: 456-59, 1995.
28. Gardner P, Griffin WB, Swartz MN, Kunz LJ. Nonfermentative Gram-negative bacilli of nosocomial interest. Am J Med 48: 735-49, 1970.
29. George R, Cochran C, Wheeler W. Epidemic meningitis of the newborn caused by Flavobacterium. Am J Dis Child 101: 296-304, 1961.
30. Gilardi G. Cultural and biochemical aspects for identification of glucose-nonfermenting gram-negative rods. In: Gilardi GL, eds. Nonfermentative gram-negative rods: Laboratory identification and clinical aspects. New York: Marcel Dekker, pp. 17-84, 1985.
31. Gokul BN, Chandramukhi A, Ravikumar R, Aroor S. Flavobacterium meningosepticum meningitis in a neonate. Ind J Pediatr 56: 524-27, 1989.
32. Harrington SP, Perlino CA. Flavobacterium meningosepticum sepsis: Disease due to bacteria with unusual antibiotic susceptibility. South Med J 74: 764-66, 1981.
33. Hawley HB, Gump DW. Vancomycin therapy of bacterial meningitis. Am J Dis Child 126: 261-64, 1973.
34. Hazuka BT, Dajani AS, Talbot K, Keen BM. Two outbreaks of Flavobacterium meningosepticum type E in a neonatal intensive care unit. J Clin Microbiol 6: 450-55, 1977.
35. Hirsh BE, Wong B, Kiehn TE, Gee T, Armstrong D. Flavobacterium meningosepticum bacteremia in an adult with acute leukemia. Use of rifampin to clear persistent infection. Diagn Microbiol Infect Dis 4: 65-69, 1986.
36. Holmes B. Identification and distribution of Flavobacterium meningosepticum in clinical material. J Appl Bacteriol 62: 29-41, 1987.
37. Humphreys H, Lovering A, White LO, Williams EW. Flavobacterium meningosepticum infection, in a 32-day-old child on acute peritoneal dialysis, treated with ciprofloxacin. J Antimicrob Chemother 23: 292-94, 1989.
38. Johny M, Khuffash FA, Elhag KM. Antimicrobial treatment of Flavobacterium meningosepticum infection. Ann Trop Paediatr 3: 125-28, 1983.
39. Kaplan M, Goldberg MD, Tauber Z, Solomon F, Sompolinsky D. Successful treatment of neonatal Flavobacterium meningosepticum infection. Eur J Pediatr 140: 337-38, 1983.
40. Kelsey MC, Emmerson AM, Drabu Y. Flavobacterium meningosepticum ventriculitis: In vivo and in vitro results with the combinations rifampicin-erythromycin and mezlocillin-cefoxitin. Eur J Clin Microbiol 1: 138-43, 1982.
41. King E. Studies on a group of previously unclassified bacteria associated with meningitis in infants. Am J Clin Pathol 31: 241-47, 1959.
42. Klein NC, Cunha BA. Tetracyclines. Med Clin North Am 79: 789-801, 1995.
43. Lapage SP, Owen RJ. Flavobacterium meningosepticum from cases of meningitis in Botswana and England. J Clin Pathol 26: 747-49, 1973.
44. Lee EL, Robinson MJ, Thong ML, Puthucheary SD. Rifamycin in neonatal flavobacteria meningitis. Arch Dis Child 51: 209-13, 1976.
45. LeFrancois M, Baum JL. Flavobacterium endophthalmitis following keratoplasty. Use of a tissue culture medium-stored cornea. Arch Ophthalmol 94: 1907-9, 1976.
46. Linder N, Korman SH, Eyal F, Michel J. Trimethoprim sulphamethoxazole in neonatal Flavobacterium meningosepticum infection. Arch Dis Child 59: 682-84, 1984.
47. Maderazo EG, Bassaris HP, Quintiliani R. Flavobacterium meningosepticum meningitis in a newborn infant. Treatment with intraventricular erythromycin. J Pediatr 85: 675-76, 1974.
48. Madruga M, Zanon U, Pereira GM, Galvao AC. Meningitis caused by Flavobacterium meningosepticum. The first epidemic outbreak of meningitis in the newborn in South America. J Infect Dis 121: 328-30, 1970.
49. Mani RM, Kuruvila KC, Batliwala PM, Damle PN, Shirgaonkar GV, Soni RP, Vyas PR. Flavobacterium meningosepticum as an opportunist. J Clin Pathol 31: 220-22, 1978.
50. Marnejon T, Watanakunakorn C. Flavobacterium meningo-septicum septicemia and peritonitis complicating CAPD [letter]. Clin Nephrol 38: 176-77, 1992.
51. Miyazaki S. Biological activities of partially purified elastase produced by Flavobacterium meningosepticum. Microbiol Immunol 28: 1083-92, 1984.
52. Muder RR, Brennen C, Goetz AM, Wagener MM, Rihs JD. Association with prior fluoroquinolone therapy of widespread ciprofloxacin resistance among Gram-negative isolates in a Veterans Affairs medical center. Antimicrob Agents Chemother 35: 256-58, 1991.
53. Nadarajah M, Tan TH. Flavobacterium meningosepticum infections. Singapore Med J 20: 293-96, 1979.
54. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing; 5th informational supplement. Vol. 14. [NCCLS Document M100-S5.) Villanova, Penn.: NCCLS, 1994.
55. Olsen H. A clinical analysis of 10 cases of postoperative infection with Flavobacterium meningosepticum. Dan Med Bull 14: 1-5, 1967.
56. Olsen H. Flavobacterium meningosepticum isolated from outside hospital surroundings and during routine examination of patient specimens. Acta Pathol Microbiol Scand 75: 313-22, 1969.
57. Olsen H, Frederiksen W, Siboni K. Flavobacterium meningosepticum in 8 non-fatal cases of postoperative bacteremia. Lancet 1: 1294-96, 1965.
58. Pickett MJ. Methods for identification of flavobacteria. J Clin Microbiol 27: 2309-15, 1989.
59. Plotkin SA, McKitrick JC. Nosocomial meningitis of the newborn caused by a flavobacterium. JAMA 198: 662-64, 1966.
60. Pokrywka M, Viazanko K, Medvick J, Knabe S, McCool S, Pasculle AW, Dowling JN. A Flavobacterium meningosepticum outbreak among intensive care patients. Am J Infect Control 21: 139-45, 1993.
61. Pons VG, Denlinger SL, Guglielmo BJ, Octavio J, Flaherty J, Derish PA, Wilson CB. Ceftizoxime versus vancomycin and gentamicin in neurosurgical prophylaxis: A randomized, prospective, blinded clinical study [see comments]. Neurosurgery 33: 416-23, 1993.
62. Raimondi A, Moosdeen F, Williams JD. Antibiotic resistance pattern of Flavobacterium meningosepticum. Eur J Clin Microbiol 5: 461-63, 1986.
63. Ratner H. Flavobacterium meningosepticum. Infect Control 5: 237-39, 1984.
64. Rios I, Klimek JJ, Maderazo E, Quintiliani R. Flavobacterium meningosepticum meningitis: Report of selected aspects. Antimicrob Agents Chemother 14: 444-47, 1978.
65. Sarvamangala JN, Venkatesh A, Shivananda PG. Flavobacterial meningitis in an infant. Ind J Pediatr 50: 93-95, 1983.
66. Scully BE, Neu HC. Oral ciprofloxacin therapy of infection caused by multiply resistant bacteria other than Pseudomonas aeruginosa. J Antimicrob Chemother 18: 179-85, 1986.
67. Seligman R, Komarov M, Reitler R. Flavobacterium meningosepticum in Israel. Br Med J 2: 1528-29, 1963.
68. Senquiz AL. Neonatal meningitis by Flavobacterium meningosepticum. Bol Assoc Med P R 79: 464-66, 1987.
69. Sexton DJ, Houk PC, Grantham RN. Successful treatment of prosthetic valve endocarditis due to Flavobacterium meningosepticum [letter]. South Med J 78: 1267-68, 1985.
70. Sharma S, Srinivasan S, Sambasiva Rao R, Murali MV, Pun RK. Flavobacterium meningitis [letter]. Ind Pediatr 21: 582, 1984.
71. Sheridan RL, Ryan CM, Pasternack MS, Weber JM, Tompkins RG. Flavobacterial sepsis in massively burned pediatric patients. Clin Infect Dis 17: 185-87, 1993.
72. Shewan JM, McMeekin TA. Taxonomy (and ecology) of Flavobacterium and related genera. Annu Rev Microbiol 37: 233-52, 1983.
73. Shulman B, Johnson M. A case of meningitis in a premature infant due to a proteolytic Gram-negative bacillus. J Lab Clin Med 26: 500-507, 1944.
74. Skapek SX, Jones WS, Hoffman KM, Kuskie MR. Sinusitis and bacteremia caused by Flavobacterium meningosepticum in a sixteen-year-old with Shwachman Diamond syndrome. Pediatr Infect Dis J 11: 411-13, 1992.
75. Sugathadasa A, Arseculeratne A. Neonatal meningitis caused by new serotype of Flavobacterium meningosepticum. Br Med J 1: 37-38, 1963.
76. Sundin D, Gold BD, Berkowitz FE, Schwartz DA, Goo D. Community-acquired Flavobacterium meningosepticum meningitis, pneumonia and septicemia in a normal infant. Pediatr Infect Dis J 10: 73-76, 1991.
77. Tam AY, Yung RW, Fu KH. Fatal pneumonia caused by Flavobaeterium meningosepticum. Pediatr Infect Dis J 8: 252-54, 1989.
78. Teres D. ICU-acquired pneumonia due to Flavobacterium meningosepticum. JAMA 228: 732, 1974.
79. Thong ML, Puthucheary SD, Lee EL. Flavobacterium meningosepticum infection: An epidemiological study in a newborn nursery. J Clin Pathol 34: 429-33, 1981.
80. Uchihara T, Yokota T, Watabiki S, Ueki M, Miyake S, Tsukagoshi H. Flavobacterium meningosepticum meningitis in an adult. Am J Med 86: 738-39, 1988.
81. Watson KC, Krogh JG, Jones DT. Neonatal meningitis caused by flavobacterium meningosepticum type F. J Clin Pathol 19: 79-80, 1966.
82. Werthamer S, Weiner M. Subacute bacterial endocarditis due to Flavobacterium meningosepticum. Am J Clin Pathol 57: 410-12, 1972.
83. Winslow DL, Pankey GA. Successful therapy with rifampin -Flavobacterium meningosepticum meningitis developing while on erythromycin therapy. Del Med J 54: 575-79, 1982.
84. Yabuuchi E, Oyama A, Takeda H, Sugiyama M, Kono S. Flavobacterium meningosepticum from neonatal meningitis. Jpn J Microbiol 14: 241-42, 1970.